Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sub C gp140 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Recipient : National Institute of Allergy and Infectious Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sub C gp140 Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of HIV Infections.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
June 20, 2011
Lead Product(s) : Sub C gp140 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Recipient : National Institute of Allergy and Infectious Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable